Revenue and Profit Performance
First written in FY2018-Q3. 15 of 33 entries say "Advanced", first in FY2018. Latest entry: 2026-10-15.
- FY2027-H1AdvancedAnnual report
「As these initiatives progressed, our group's revenue for the interim consolidated accounting period was ¥3,524 million, up 5.5% year on year, gross profit was ¥1,560 million, up 5.1%, and operating income was ¥556 million, up 47.5%.」
Interim revenue, gross profit, operating income, ordinary income, and interim net income attributable to owners of the parent exceeded the same period of the previous year, with operating income rising 47.5%. - 2026-07-15OtherEarnings
「Net sales were ¥1,799 million, up 2.1% year on year; gross profit was ¥817 million, up 5.8%; and operating income was ¥316 million, up 97.4%.」
The Company updated the first-quarter results for net sales, gross profit, and operating income. - FY2026Slight revenue growth, lower operating profit, lower ordinary profit and lower net profitAnnual report
「For the current consolidated fiscal year, net sales were ¥6,394.414 million, up 0.4% year on year, operating income was ¥747.678 million, down 6.2%, ordinary income was ¥666.969 million, down 19.4%, and net income attributable to owners of the parent was ¥427.358 million, down 30.6%.」
While full-year net sales increased slightly, operating income, ordinary income and net income attributable to owners of the parent all declined. - FY2026-H1Revenue growth, lower operating income, lower ordinary income and lower net incomeAnnual report
「As these initiatives progressed, the Group's net sales for the current interim consolidated accounting period were ¥3,340 million, up 2.0% year on year, gross profit was ¥1,484 million, up 1.1%, and operating income was ¥377 million, down 24.2%. After recording ¥13 million in rental income and ¥3 million in interest income as non-operating income, and ¥6 million in interest expense and ¥5 million in foreign exchange losses as non-operating expenses, ordinary income was ¥374 million, down 28.0% year on year. As a result, interim net income attributable to owners of the parent was ¥239 million, down 42.5% year on year.」
Although interim consolidated net sales increased, operating income, ordinary income and interim net income attributable to owners of the parent were all below the same period of the previous year. - FY2025-H1Revenue decline, operating profit decline, ordinary profit decline and net profit growthAnnual report
「As a result, the Group's net sales for the current interim consolidated accounting period were ¥3,274 million, down 0.3% year on year, following the launch of the new product "ジスタ／Zista" in March 2024 and firm shipments of walking-related products, the Company's core category. On the income side, gross profit was ¥1,468 million, down 4.6%, and operating income was ¥497 million, down 12.1%, due to higher procurement costs resulting from the weaker yen and higher logistics costs, including freight. After recording ¥27 million in rental income and ¥22 million in foreign exchange gains as non-operating income, and ¥13 million in rental expenses and ¥8 million in interest expense as non-operating expenses, ordinary income was ¥520 million, down 7.7% year on year. After recording a ¥61 million gain on the sale of fixed assets as extraordinary income and a ¥4 million impairment loss as an extraordinary loss, income before income taxes was ¥578 million, up 2.7% year on year. As a result, interim net income attributable to owners of the parent was ¥416 million, up 11.7% year on year, following the recognition of ¥147 million in corporate, inhabitant and enterprise taxes and ¥3 million in adjustments to corporate taxes, among other items.」
While cumulative interim consolidated net sales, operating income and ordinary income were below the same period of the previous year, interim net income attributable to owners of the parent exceeded the previous year's level, mainly due to gains on the sale of fixed assets. - FY2025-Q1Lower revenue, lower operating income, higher net incomeAnnual report
「For the cumulative first quarter of the current consolidated fiscal year, the Group's net sales were ¥1,725 million, down 0.9% year on year, as the new product "ジスタ/Zista" was launched in March 2024 and shipments of walking-related products, the Company's core category, remained firm. Gross profit was ¥791 million, down 4.2%, and operating income was ¥298 million, down 10.8%.」
While net sales, gross profit, operating income and ordinary income were below the same period of the previous year, net income attributable to owners of the parent was ¥225 million, up 7.7% year on year. - FY2024AdvancedAnnual report
「For the consolidated fiscal year, net sales amounted to ¥6,404.012 million, up 2.2% year on year; operating profit was ¥948.371 million, up 46.1%; ordinary profit was ¥936.869 million, up 40.5%; and profit attributable to owners of the parent was ¥710.429 million, up 62.1%.」
Full-year net sales, operating income, ordinary income and net income attributable to owners of the parent all exceeded the previous fiscal year's levels. - FY2024-Q3AdvancedAnnual report
「Operating profit was ¥784 million, up 53.5% year on year. Non-operating income included ¥40 million in rental income and ¥13 million in commissions received, while non-operating expenses included ¥45 million in foreign exchange losses and ¥19 million in rental expenses. As a result, ordinary profit was ¥775 million, up 40.0% year on year. … Profit attributable to owners of the parent was ¥477 million, up 30.5% year on year.」
Net sales were ¥4,893 million, operating profit was ¥784 million, ordinary profit was ¥775 million and profit attributable to owners of the parent was ¥477 million, with each profit measure exceeding the previous year's level. - FY2024-Q2AdvancedAnnual report
「Consolidated net sales for the six months ended 30 September amounted to ¥3,285 million, up 3.7% year on year, as shipments of mobility-related products, the company's core category, remained firm. Gross profit was ¥1,539 million, up 17.9%. … Operating profit was ¥566 million, up 92.7% year on year. … Ordinary profit was ¥563 million, up 89.1%. … Profit attributable to owners of the parent was ¥372 million, up 98.5%.」
Firm shipments of mobility-related products, profitability improvement measures and cost reductions lifted net sales, operating profit, ordinary profit and profit attributable to owners of the parent above the previous year's levels. - FY2024-Q1AdvancedAnnual report
「As shipments of mobility-related products, the company's core category, remained firm, sales amounted to ¥1,740 million, up 3.4% year on year, and gross profit was ¥826 million, up 12.5%. Although the company was affected by higher logistics costs, including freight charges, operating profit increased 47.2% year on year to ¥334 million as it implemented various measures to improve profitability and pursued thorough cost reductions. … Ordinary profit was ¥318 million, up 46.8% year on year. … Profit attributable to owners of the parent was ¥209 million, up 52.5%.」
In the first quarter, revenue increased, and operating profit, ordinary profit and profit attributable to owners of the parent exceeded the previous year's levels. - FY2023-Q3Revenue growth, lower operating profit, higher ordinary profit, lower net profitAnnual report
「Consolidated net sales for the nine months ended 31 December amounted to ¥4,784 million, compared with ¥4,389 million in the same period of the previous year, as sales of walking aids, led by "Citrea," remained strong. Gross profit after deducting the provision for sales returns was ¥2,015 million, compared with ¥2,098 million in the same period of the previous year.」
Net sales increased from ¥4,389 million in the previous year to ¥4,784 million, while operating profit was ¥511 million, down 5.8% year on year. Ordinary profit was ¥553 million, up 4.3%, and profit attributable to owners of the parent was ¥365 million, down 0.9%. - FY2023-Q2Revenue growth, lower operating profit, lower net profitAnnual report
「The group's net sales amounted to ¥3,167 million, compared with ¥2,882 million in the same quarter of the previous year, as sales of walking aids, led by "Citrea," remained firm. Gross profit was ¥1,305 million, compared with ¥1,389 million in the same quarter of the previous year. Although the company pursued fixed-cost controls, operating profit declined 17.5% year on year to ¥293 million due partly to higher logistics costs, including freight charges.」
Net sales increased from ¥2,882 million in the same quarter of the previous year to ¥3,167 million, while operating profit was ¥293 million, ordinary profit was ¥298 million and profit attributable to owners of the parent was ¥187 million, all down year on year. - FY2023-Q1Operating profit increases, net profit declinesAnnual report
「Operating profit was ¥227 million, up 3.2% year on year. … Ordinary profit was ¥216 million, up 0.9% year on year. … Profit attributable to owners of the parent was ¥137 million, down 4.1% year on year.」
Net sales amounted to ¥1,683 million, and operating and ordinary profit exceeded the previous year's levels, while profit attributable to owners of the parent declined 4.1% year on year. - FY2022AdvancedAnnual report
「For the consolidated fiscal year, net sales amounted to ¥5,717.345 million, up 9.6% year on year; operating profit was ¥590.441 million, up 60.1%; ordinary profit was ¥545.808 million, up 40.5%; and profit attributable to owners of the parent was ¥400.961 million, up 3.0%.」
The full-year net sales, operating profit, ordinary profit and profit attributable to owners of the parent have been updated. Operating profit increased 60.1% year on year. - FY2022-Q3AdvancedAnnual report
「As a result, consolidated net sales for the nine months ended 31 December amounted to ¥4,389 million, up 8.5% year on year, and gross profit after deducting the provision for sales returns was ¥2,098 million, up 2.3% year on year, as sales of walking aids, led by "Citrea," launched in November 2020, remained strong despite some impact from the state of emergency declaration. Although raw-material and logistics costs rose due to higher crude oil prices, operating profit increased 67.4% year on year to ¥542 million as the company continued to control fixed costs.」
Net sales and gross profit increased, and fixed-cost controls contributed to a 67.4% year-on-year increase in operating profit. Ordinary profit was ¥530 million and profit attributable to owners of the parent was ¥368 million. - FY2022-Q2AdvancedAnnual report
「As a result, consolidated net sales for the six months ended 30 September amounted to ¥2,882 million, up 9.4% year on year, as sales of walking aids, led by "Citrea," launched in November 2020, remained firm despite some impact from the state of emergency declaration. Gross profit after deducting the provision for sales returns was ¥1,389 million, up 3.6% year on year.」
Net sales were ¥2,882 million, operating profit was ¥356 million, ordinary profit was ¥350 million and profit attributable to owners of the parent was ¥239 million, resulting in higher sales and profit than in the previous year. - FY2022-Q1AdvancedAnnual report
「As a result, consolidated net sales for the three months ended 30 June amounted to ¥1,518 million, up 20.8% year on year. Although the reissuance of a state of emergency declaration due to the resurgence of COVID-19 affected part of the chain-store route, the company's core walking aids remained firm even as people were asked to refrain from going out, having gained recognition as essential goods. In addition, orders for the walking aid "Citrea," launched in November 2020, through the healthcare route remained strong.」
Despite the continuing impact of the resurgence of COVID-19 in some areas, firm walking aid sales and strong orders for Citrea drove a 20.8% year-on-year increase in net sales. Operating profit was ¥220 million, ordinary profit was ¥214 million and profit attributable to owners of the parent was ¥143 million. - FY2021-Q2Revenue declines, but operating and ordinary profit increase; net profit declinesAnnual report
「As a result, consolidated net sales for the six months ended 30 September amounted to ¥2,634 million, down 23.2% year on year, due to restrictions on people's movements and the suspension of sales activities to customers and others resulting from the spread of COVID-19. Gross profit after deducting the provision for sales returns was ¥1,341 million, down 17.3% year on year.」
Although net sales and gross profit were below the previous year's levels, operating profit was ¥161 million and ordinary profit was ¥189 million, supported by fixed-cost controls resulting from organizational reviews and improved operating efficiency. Profit attributable to owners of the parent was ¥150 million after recording an extraordinary loss. - FY2021-Q1WorsenedAnnual report
「As a result, consolidated net sales for the three months ended 30 June amounted to ¥1,257 million, down 30.2% year on year, and gross profit after deducting the provision for sales returns was ¥631 million, down 26.4% year on year, due to the issuance of a state of emergency declaration by the government and the resulting stagnation in economic activity caused by the spread of COVID-19.」
Due to the impact of COVID-19, net sales declined 30.2% year on year. Operating profit was ¥47 million, ordinary profit was ¥58 million and profit attributable to owners of the parent declined to ¥27 million. - FY2020Sales recovery and narrower operating loss, but net loss continuesAnnual report
「For the consolidated fiscal year, net sales amounted to ¥5,992.157 million, up 32.4% year on year; the operating loss was ¥131.310 million, compared with an operating loss of ¥272.882 million in the previous year; the ordinary loss was ¥110.653 million, compared with an ordinary loss of ¥262.200 million; and the loss attributable to owners of the parent was ¥367.327 million, compared with a loss attributable to owners of the parent of ¥358.158 million in the previous year.」
Net sales increased and operating and ordinary losses narrowed, but the net loss attributable to owners of the parent continued and widened from the previous year due to valuation losses on investment securities, impairment losses and other factors. - FY2020-Q3Operating recovery, but net loss continues due to extraordinary lossesAnnual report
「As a result, consolidated net sales for the nine months ended 31 December amounted to ¥4,804 million, up 34.4% year on year, as the company launched the new women's rollator-type walking aid "Michelle," the impact of the voluntary recall that occurred in the previous consolidated fiscal year subsided, orders through the healthcare route recovered, a large order for rollators from South Korea was shipped, and sales from newly added consolidated subsidiaries contributed. Gross profit after deducting the provision for sales returns was ¥2,300 million, up 39.2% year on year.」
Sales were ¥4,804 million, operating profit was ¥64 million and ordinary profit was ¥103 million, representing an improvement in operating performance from the previous year. However, due to an impairment loss of ¥203 million, a valuation loss on investment securities of ¥76 million and other factors, the loss attributable to owners of the parent was ¥159 million. - FY2020-Q2AdvancedAnnual report
「As a result, consolidated net sales for the six months ended 30 September amounted to ¥3,429 million, up 43.6% year on year, as the impact of the voluntary recall that occurred in the previous consolidated fiscal year subsided, orders through the healthcare route recovered, a large order for rollators from South Korea was shipped, and sales from newly added consolidated subsidiaries contributed. Gross profit after deducting the provision for sales returns was ¥1,622 million, up 48.1% year on year.」
The impact of the voluntary recall subsided, orders through the healthcare route recovered, the large order for South Korea was shipped, and consolidated subsidiaries contributed to sales, improving sales and profit from the previous year. Operating profit was ¥105 million, ordinary profit was ¥167 million and profit attributable to owners of the parent was ¥174 million. - FY2020-Q1AdvancedAnnual report
「As a result, consolidated net sales for the three months ended 30 June amounted to ¥1,802 million, up 42.3% year on year, as the impact of the voluntary recall that occurred in the previous consolidated fiscal year subsided, orders through the healthcare route recovered, and sales from newly added consolidated subsidiaries contributed. Gross profit after deducting the provision for sales returns was ¥858 million, up 43.3% year on year.」
The impact of the voluntary recall subsided, orders through the healthcare route recovered, and sales from newly consolidated subsidiaries contributed, substantially improving sales and profit from the previous year. Operating profit was ¥94 million, ordinary profit was ¥146 million and profit attributable to owners of the parent was ¥147 million. - FY2019WorsenedAnnual report
「For the consolidated fiscal year, net sales amounted to ¥4,526.297 million, down 11.1% year on year; the company posted an operating loss of ¥272.882 million, compared with operating profit of ¥562.460 million in the previous year; an ordinary loss of ¥262.200 million, compared with ordinary profit of ¥453.095 million; and a loss attributable to owners of the parent of ¥358.158 million, compared with profit attributable to owners of the parent of ¥356.397 million.」
Net sales declined, while operating profit, ordinary profit and profit attributable to owners of the parent all turned into losses. - FY2019-Q3AdvancedAnnual report
「As a result, consolidated net sales for the nine months ended 31 December amounted to ¥3,575 million, down 9.7% year on year, partly due to the substantial constraints on operating activities arising from measures taken in response to the voluntary recall of the rollator-type walking aid "Michele."」
For the nine months ended 31 December, net sales were ¥3,575 million, an operating loss of ¥51 million, an ordinary loss of ¥23 million and a loss attributable to owners of the parent of ¥117 million. The constraints on operating activities caused by the response to Michele's voluntary recall were identified as a factor behind the deterioration in performance. - FY2019-Q2AdvancedAnnual report
「As a result, consolidated net sales for the six months ended 30 September amounted to ¥2,387 million, down 12.6% year on year, partly due to the suspension of shipments associated with the voluntary recall of the rollator-type walking aid "Michele," for which sales expansion had been planned during the period.」
For the six months ended 30 September, net sales were ¥2,387 million, down 12.6% year on year. The company posted an operating loss of ¥62 million, an ordinary loss of ¥38 million and a loss attributable to owners of the parent of ¥133 million. The impact of Michele's voluntary recall and shipment suspension was identified as a performance factor. - FY2019-Q1AdvancedAnnual report
「Net sales for the three months ended 30 June amounted to ¥1,266 million, as the decline in sales caused by inventory adjustments by welfare-equipment rental and sales operators outweighed firm overseas orders. Selling, general and administrative expenses were ¥580 million, resulting in operating profit of ¥18 million. Non-operating income included ¥12 million in proceeds from a government subsidy program and ¥2 million in foreign exchange gains, while non-operating expenses included ¥5 million in sales discounts and other items. Consequently, ordinary profit was ¥29 million, and profit attributable to owners of the parent was ¥8 million after recording ¥21 million in income taxes.」
The results for the first quarter have been updated, including net sales, operating profit, ordinary profit and profit attributable to owners of the parent. - FY2018AdvancedAnnual report
「Net sales amounted to ¥5,093.256 million, up 11.5% year on year; operating profit was ¥562.460 million, up 71.5%; ordinary profit was ¥453.095 million, up 49.2%; and profit attributable to owners of the parent was ¥356.397 million, up 69.3%.」
The figures have been updated from the nine-month cumulative results to the full-year results, showing full-year net sales, operating profit, ordinary profit and net income, together with year-on-year changes. - FY2018-Q3First statedAnnual report
「As a result, profit attributable to owners of the parent amounted to ¥299 million, after recording ¥95 million in income taxes.」
The main profit figures for the nine-month period are reported. Net sales were ¥3,959 million and ordinary profit was ¥404 million.